Literature DB >> 25731725

Surface chemistry and serum type both determine the nanoparticle-protein corona.

Daniela Pozzi1, Giulio Caracciolo2, Anna Laura Capriotti3, Chiara Cavaliere3, Giorgia La Barbera3, Thomas J Anchordoquy4, Aldo Laganà3.   

Abstract

The protein corona that forms around nanoparticles in vivo is a critical factor that affects their physiological response. The potential to manipulate nanoparticle characteristics such that either proteins advantageous for delivery are recruited and/or detrimental proteins are avoided offers exciting possibilities for improving drug delivery. In this work, we used nanoliquid chromatography tandem mass spectrometry to characterize the corona of five lipid formulations after incubation in mouse and human plasma with the hope of providing data that may contribute to a better understanding of the role played by both the nanoparticle properties and the physiological environment in recruiting specific proteins to the corona. Notably, we showed that minor changes in the lipid composition might critically affect the protein corona composition demonstrating that the surface chemistry and arrangement of lipid functional groups are key players that regulate the liposome-protein interactions. Notably, we provided evidence that the protein corona that forms around liposomes is strongly affected by the physiological environment, i.e., the serum type. These results are likely to suggest that the translation of novel pharmaceutical formulations from animal models to the clinic must be evaluated on a case-by-case basis. BIOLOGICAL SIGNIFICANCE: In the present work nanoliquid chromatography tandem mass spectrometry was used to characterize the protein corona of five different liposome formulations after exposure to mouse and human plasma. The modern proteomic methods employed have clarified that the arrangement of lipid functional groups is a key player that regulates the liposome-protein interactions. We also clarified that the protein corona enrichment and complexity depend on the serum type. Our results suggest that the translational of novel pharmaceutical formulations from animal models to the clinic must be evaluated on a case-by-case basis.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Human plasma; Liposomes; Mouse plasma; Nanoliquid chromatography tandem mass spectrometry; Nanoparticles; Protein corona

Mesh:

Substances:

Year:  2015        PMID: 25731725      PMCID: PMC4441341          DOI: 10.1016/j.jprot.2015.02.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  21 in total

1.  Label-free quantitative analysis for studying the interactions between nanoparticles and plasma proteins.

Authors:  Anna Laura Capriotti; Giulio Caracciolo; Giuseppe Caruso; Chiara Cavaliere; Daniela Pozzi; Roberto Samperi; Aldo Laganà
Journal:  Anal Bioanal Chem       Date:  2012-01-25       Impact factor: 4.142

2.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.

Authors:  Stefan Tenzer; Dominic Docter; Jörg Kuharev; Anna Musyanovych; Verena Fetz; Rouven Hecht; Florian Schlenk; Dagmar Fischer; Klytaimnistra Kiouptsi; Christoph Reinhardt; Katharina Landfester; Hansjörg Schild; Michael Maskos; Shirley K Knauer; Roland H Stauber
Journal:  Nat Nanotechnol       Date:  2013-09-22       Impact factor: 39.213

3.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.

Authors:  Martin Lundqvist; Johannes Stigler; Giuliano Elia; Iseult Lynch; Tommy Cedervall; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

4.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.

Authors:  Marco P Monopoli; Dorota Walczyk; Abigail Campbell; Giuliano Elia; Iseult Lynch; Francesca Baldelli Bombelli; Kenneth A Dawson
Journal:  J Am Chem Soc       Date:  2011-02-02       Impact factor: 15.419

5.  Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.

Authors:  Stefan Tenzer; Dominic Docter; Susanne Rosfa; Alexandra Wlodarski; Jörg Kuharev; Alexander Rekik; Shirley K Knauer; Christoph Bantz; Thomas Nawroth; Carolin Bier; Jarinratn Sirirattanapan; Wolf Mann; Lennart Treuel; Reinhard Zellner; Michael Maskos; Hansjörg Schild; Roland H Stauber
Journal:  ACS Nano       Date:  2011-08-25       Impact factor: 15.881

Review 6.  Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.

Authors:  Giulio Caracciolo
Journal:  Nanomedicine       Date:  2014-12-30       Impact factor: 5.307

Review 7.  Biomolecular coronas provide the biological identity of nanosized materials.

Authors:  Marco P Monopoli; Christoffer Aberg; Anna Salvati; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2012-12       Impact factor: 39.213

8.  Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes.

Authors:  Tatsuhiro Ishida; Masae Harada; Xin Yu Wang; Masako Ichihara; Kenji Irimura; Hiroshi Kiwada
Journal:  J Control Release       Date:  2005-07-20       Impact factor: 9.776

Review 9.  Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.

Authors:  Janos Szebeni; Franco Muggia; Alberto Gabizon; Yechezkel Barenholz
Journal:  Adv Drug Deliv Rev       Date:  2011-07-14       Impact factor: 15.470

10.  Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum.

Authors:  Giulio Caracciolo; Luciano Callipo; Sofia Candeloro De Sanctis; Chiara Cavaliere; Daniela Pozzi; Aldo Laganà
Journal:  Biochim Biophys Acta       Date:  2009-11-14
View more
  15 in total

1.  Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.

Authors:  Jie Wang; Ze Lu; Junfeng Wang; Minjian Cui; Bertrand Z Yeung; David J Cole; M Guillaume Wientjes; Jessie L-S Au
Journal:  J Control Release       Date:  2015-08-10       Impact factor: 9.776

Review 2.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

Review 3.  Toward a systematic exploration of nano-bio interactions.

Authors:  Xue Bai; Fang Liu; Yin Liu; Cong Li; Shenqing Wang; Hongyu Zhou; Wenyi Wang; Hao Zhu; David A Winkler; Bing Yan
Journal:  Toxicol Appl Pharmacol       Date:  2017-03-24       Impact factor: 4.219

Review 4.  Personalized protein corona on nanoparticles and its clinical implications.

Authors:  Claudia Corbo; Roberto Molinaro; Mateen Tabatabaei; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

Review 5.  Current approaches of nanomedicines in the market and various stage of clinical translation.

Authors:  Xiaoting Shan; Xiang Gong; Jie Li; Jingyuan Wen; Yaping Li; Zhiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2022-03-01       Impact factor: 14.903

Review 6.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

7.  Biological Fate of Fe₃O₄ Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry.

Authors:  Estelle Rascol; Morgane Daurat; Afitz Da Silva; Marie Maynadier; Christophe Dorandeu; Clarence Charnay; Marcel Garcia; Joséphine Lai-Kee-Him; Patrick Bron; Mélanie Auffan; Wei Liu; Bernard Angeletti; Jean-Marie Devoisselle; Yannick Guari; Magali Gary-Bobo; Joël Chopineau
Journal:  Nanomaterials (Basel)       Date:  2017-06-30       Impact factor: 5.076

8.  Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration.

Authors:  Marc Sangrà; Joan Estelrich; Raimon Sabaté; Alba Espargaró; Maria Antònia Busquets
Journal:  Nanomaterials (Basel)       Date:  2017-02-10       Impact factor: 5.076

9.  Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective.

Authors:  Aya Ahmed Sebak; Iman Emam Omar Gomaa; Aliaa Nabil ElMeshad; Mahmoud Hussien Farag; Ulrike Breitinger; Hans-Georg Breitinger; Mahmoud Hashem AbdelKader
Journal:  Int J Nanomedicine       Date:  2020-11-10

10.  Machine learning predicts the functional composition of the protein corona and the cellular recognition of nanoparticles.

Authors:  Zhan Ban; Peng Yuan; Fubo Yu; Ting Peng; Qixing Zhou; Xiangang Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.